Aktieanalys

Analyst Group Comment on STENOCARE’s Product Approval in Germany

{newsItem.title}

Analyst Group Publicerad: 25 May 2023 12:45

STENOCARE announced on May 25th, that a new medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for prescription-based sales to German patients.

Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-stenocares-product-approval-in-germany/

Nyheter om Stenocare

Läses av andra just nu

Om aktien Stenocare

Senaste nytt